Form 8-K - Current report:
SEC Accession No. 0001628280-21-003278
Filing Date
2021-02-25
Accepted
2021-02-25 16:02:10
Documents
3
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k022521.htm 8-K 29073
2 EX-99.1 a991crdf022521.htm EX-99.1 142018
3 cardiff_logoxrgbxtm1a.jpg GRAPHIC 176318
  Complete submission text file 0001628280-21-003278.txt   400790
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 21680163
SIC: 2836 Biological Products, (No Diagnostic Substances)